We design and produce nanoparticles for enhanced delivery of medicines for treatment of cancer and infections. We combine nanotechnology with ultrasound technology to achieve targeted diagnostics and treatment.
SINTEF has modern infrastructure especially suited for advanced characterization of nanoparticles. We have many years of experience and expertise within cell-based screening technology, toxicology and uptake of nanoparticles, and experience within the use of various animal models for cancer and inflammation.
Research teams related to Nanomedicine in SINTEF: